Filing Details
- Accession Number:
- 0000950170-24-058878
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-13 18:07:34
- Reporting Period:
- 2024-05-10
- Accepted Time:
- 2024-05-13 18:07:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1630627 | Treace Medical Concepts Inc. | TMCI | Surgical & Medical Instruments & Apparatus (3841) | 471052611 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1856380 | T. John Treace | C/O Treace Medical Concepts, Inc. 100 Palmetto Park Place Ponte Vedra FL 32081 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-10 | 150,000 | $4.58 | 5,943,095 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-05-13 | 150,000 | $4.56 | 6,093,095 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,605,000 | Indirect | By spouse |
| Common Stock | 1,471,250 | Indirect | By spouse as co-trustee of a trust |
| Common Stock | 1,839,063 | Indirect | as trustee of a trust |
| Common Stock | 408,816 | Indirect | as co-trustee of a trust |
Footnotes
- The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.4700 to $4.7500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
- Includes 196,646 restricted stock units
- The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.3900 to $4.6400 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
- The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
- The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as trustee or co-trustee.
Billionaire Hedge Funds
